CRISPR Therapeutics Proposes New Appointment to the Board of Directors
CRISPR Therapeutics(CRSP) Newsfilter·2024-03-13 12:30ZUG, Switzerland and BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced it proposes to elect Christian Rommel, Ph.D., to its Board of Directors at the Company's annual general meeting to be held this year. "We are thrilled to welcome Christian to our Board of Directors," said Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of the Board of CRISPR T ...